
Work Here?
Quanticate is a global data-focused CRO that supports pharmaceutical, biotechnology, and medical device companies with the data side of clinical trials. It handles Clinical Data Management, Biostatistics, SAS Programming, data quality oversight via Centralized Statistical Monitoring, Medical Writing, and Pharmacovigilance, offering study-level support, functional service provision, strategic data-solutions, or technical consultancy. Its staff work on trial data to clean and organize it, perform analyses, write reports, and monitor quality, delivered through flexible models like dedicated teams, project-based work, or full data solutions. The goal is to be the supplier of choice for data-driven clinical research by delivering accurate, timely, and compliant data solutions that help speed and improve decision-making in trials.
Industries
Data & Analytics
Consulting
Enterprise Software
Healthcare
Company Size
201-500
Company Stage
N/A
Total Funding
N/A
Headquarters
Hitchin, United Kingdom
Founded
1994
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Remote Work Options
Flexible Work Hours
Paid Vacation
Paid Holidays
Paid Sick Leave
Health Insurance
Disability Insurance
Training Programs
Quanticate announces strategic partnership with PhaseV.
Quanticate, a global biometric clinical research organization, is pleased to announce its strategic partnership with KPS Life, a US-based provider of Functional Service Provision solutions focused on clinical operations and clinical monitoring oversight.
Quanticate is pleased to announce that Quanticate Inc. has been selected as a finalist for the Excellence in Use of Real-World Evidence category in the Citeline Awards 2023.
Quanticate, a global data-focused clinical research organisation (CRO), has announced the appointment of Yolanda Barbachano as Head of Statistics.
Quanticate, a global data-focused clinical research organisation (CRO), has partnered with leading cancer research organisation, Cancer Research UK, to launch the DETERMINE study which will test a range of therapies specifically targeting key genetic changes in cancer cells. The first of its kind in the UK, the DETERMINE study will enrol patients with rare cancers, and aim to find out whether existing licensed drugs could be used to treat their type of cancer
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Consulting
Enterprise Software
Healthcare
Company Size
201-500
Company Stage
N/A
Total Funding
N/A
Headquarters
Hitchin, United Kingdom
Founded
1994
Find jobs on Simplify and start your career today